Journal ArticleOPEN ACCESS

DSUVmax for interim PET in DLBCL: old is new

Blood (2020) 135(25) 2202-2203
DOI: 10.1182/BLOOD.2020005649
7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the this issue of Blood, Schöder et al report the superior predictive value of change in maximum standardized uptake (DSUVmax) compared with Deauville score (DS) in interim positron emission tomography (i-PET) evaluation in 158 diffuse large B-cell lymphoma (DLBCL) patients treated with immunochemotherapy enrolled in the Alliance/CALGB 50303 trial.1

Cite

CITATION STYLE

APA

Meignan, M., & Gallamini, A. (2020). DSUVmax for interim PET in DLBCL: old is new. Blood, 135(25), 2202–2203. https://doi.org/10.1182/BLOOD.2020005649

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free